
Sarah Tabrizi
Professor Sarah Tabrizi is a prominent neurologist and the director of the University College London Huntington's Disease Centre. She has been instrumental in groundbreaking research on Huntington's disease, particularly in developing innovative gene therapies aimed at slowing the progression of this devastating condition. Recently, she celebrated a significant breakthrough in treatment that has shown to slow disease progression by 75%, offering hope to patients and families affected by Huntington's.
Not in the pool (under ¢1).
Recent news mentions
Sarah Tabrizi saw evidence that gene therapy can slow the progression of Huntington's disease.
El primer bebé tratado con terapia génica personalizada protagoniza las historias de ciencia más relevantes de 2025 | CienciaSarah Tabrizi is the leader of the UK part of the study on Huntington's disease.
Neue Gentherapie verlangsamt den KrankheitsverlaufSarah Tabrizi led the research work on treating Huntington's disease.
Meðhöndlun alvarlegs sjúkdóms tókst í fyrsta sinnProf Sarah Tabrizi led the UK part of the trial and described the results as 'spectacular'.
Huntington's disease successfully treated for first time
















